# DESCRIPTION

## FIELD OF THE INVENTION

- define genetic engineering tools

## BACKGROUND TO THE INVENTION

- introduce CRISPR-Cas system
- describe adaptive immune system
- summarize CRISPR-Cas system classes
- motivate Cas9 for genome editing
- describe Cas9 use in eukaryotic cells
- describe Cas9 use in bacteria
- introduce Targeting construct
- describe selection for recombination events
- establish CRISPR-Cas mediated genome editing
- motivate need for improved sequence-specific nucleic acid detection
- describe limitations of Cas9 in thermophilic organisms
- summarize presence of Cas9 in bacteria
- describe discovery of thermostable Cas9 variants
- introduce optimised PAM sequences
- describe phylogenetic re-assessment of Geobacillus
- summarize CRISPR-Cas systems
- motivate need for Cas9-based editing tool for obligate thermophiles

## SUMMARY OF THE INVENTION

- introduce ThermoCas9
- describe its in vitro activity
- demonstrate importance of sgRNA structure for thermostability
- apply ThermoCas9 for in vivo genome editing
- provide method of modifying genetic material of eukaryotic cell
- integrate polynucleotide encoding ThermoCas9 into genome
- transform cell with expression vector comprising guide RNA
- transform cell with repair oligonucleotide
- describe active fragments of ThermoCas9
- modify genome of cell first to express ThermoCas9
- transform cell with expression vector for gRNA
- transform cell with repair oligonucleotide simultaneously
- provide alternative method of modifying genetic material
- integrate polynucleotide encoding ThermoCas9 into genome
- transform cell with expression vector comprising guide RNA
- describe repair oligonucleotide
- use double-stranded DNA repair oligo
- use repair oligo to achieve deletion of desired locus
- describe promoters
- use constitutive promoter
- use inducible promoter
- describe combinations of promoters
- transform cell with expression plasmid(s) and/or repair-oligo
- provide method of modifying genetic material of prokaryotic host
- provide polynucleotide expression vector
- describe Cas9 nuclease
- describe guide RNA
- describe first promoter
- describe expression vector with HR fragment
- describe inducible promoter
- describe constitutive promoter
- describe HR fragment
- describe insertion element
- provide method of modifying genetic material of prokaryotic organism
- transform organism with expression vector
- describe temperatures for transformation and induction
- provide isolated CRISPR-associated (Cas) protein or polypeptide
- describe motifs of Cas protein or polypeptide
- list peptide sequences
- list peptide sequences
- list peptide sequences
- list peptide sequences
- list peptide sequences
- list peptide sequences
- list peptide sequences
- list peptide sequences
- list peptide sequences
- list peptide sequences
- list peptide sequences
- list peptide sequences
- list Cas protein motifs
- list Cas protein motifs
- define Cas protein
- describe motifs
- provide isolated Cas protein
- describe temperature range
- describe target polynucleotide
- describe target nucleic acid sequence
- describe non-target nucleic acid strand
- describe protospacer adjacent motif (PAM) sequence
- provide examples of PAM sequences
- describe Cas protein binding
- describe temperature range for binding
- describe Cas protein cleaving
- describe Cas protein marking
- describe Cas protein modifying
- describe uses of Cas protein
- describe method of binding
- describe method of cleaving
- describe method of marking
- describe method of modifying
- describe in vivo uses
- describe in vitro uses
- describe expression of Cas protein
- describe percentage identity with SEQ ID NO: 1
- describe characterisation of Cas protein
- describe use of targeting RNA molecule
- describe method of forming ribonucleoprotein complex
- describe concentration of Cas protein
- describe PAM sequence with adenine in eighth position
- describe PAM sequence with cytosine in fifth position
- describe nucleic acids encoding Cas protein
- describe conservative amino acid substitutions
- describe conservative nucleic acid substitutions
- describe transformed cell
- describe kits for carrying out the invention

## RNA Guides and Target Sequences

- introduce Cas proteins and target nucleic acids
- describe target nucleic acid types
- introduce guide RNAs (gRNAs) and targeting RNA molecules
- describe PAM sequences and their importance
- provide PAM sequence examples
- describe ribonucleoprotein complex composition
- outline use of ribonucleoprotein complex
- describe method of binding, cleaving, marking or modifying target nucleic acid
- introduce transformed non-human cells
- describe RNA molecule characteristics
- provide RNA molecule length ranges
- describe preferred RNA molecule length ranges
- introduce complementary portion of RNA molecule
- provide complementary portion length ranges
- describe RNA molecule specificity and affinity
- provide dissociation constant (Kd) ranges
- introduce CRISPR RNA (crRNA) molecules
- describe crRNA structure
- introduce type I-E and type II CRISPR systems
- describe RNA molecule design based on gene sequence information
- introduce SEED portion of spacer sequence
- describe SEED sequence requirements
- introduce method of detecting single base change in target nucleic acid
- describe PAM sequence design rule
- provide PAM sequence examples for different Cas9 variants
- describe influence of PAM sequence on temperature range
- define RNA guides and target sequences
- specify PAM sequences for broad temperature range
- describe targeting RNA molecule length
- specify ribonucleoprotein complex components
- describe hairpin and tetranucleotide loop forming sequence
- specify non-target nucleic acid strand PAM sequences
- describe limitations of mesophilic SpCas9
- introduce ThermoCas9 and its temperature range
- describe ThermoCas9's ability to manipulate temperature range
- identify factors conferring thermostability of ThermoCas9
- describe PAM preferences of ThermoCas9
- specify PAM sequences for binding, cleavage, marking, or modification
- describe PAM sequence alteration for efficient binding, cleavage, marking, or modification
- specify PAM sequences for target binding, cleavage, marking, or modification at 30Â°C
- describe PAM sequence options for target binding, cleavage, marking, or modification
- define PAM sequences of the invention
- describe PAM sequence composition
- specify nucleoprotein complex components
- describe ribonucleoprotein complex association with target nucleic acid strand
- conclude nucleoprotein complex description

### Binding, Cleavage, Marking and Modifying Temperatures

- introduce Cas proteins of the invention
- describe optimal temperature range
- highlight advantage in genetic engineering
- describe thermostability of Cas proteins
- discuss application in molecular biology techniques
- describe transcriptional control of target sequences
- discuss gene-silencing tool
- specify temperature range for nucleic acid binding
- specify temperature range for nucleic acid cleavage
- specify temperature range for nucleic acid marking
- specify temperature range for nucleic acid modifying
- describe PAM sequence
- describe target RNA molecules
- specify temperature range for binding, cleaving, marking and modifying
- describe alteration of PAM sequence for efficient cleavage
- describe tracrRNA and crRNA
- specify length of crRNA
- describe synthetic linker
- describe chimeric single-guide RNA (sgRNA)
- describe tracrRNA and hairpin structures
- describe deletion of tracrRNA part
- describe influence of tracrRNA structure on thermostability
- describe modification of tracrRNA for efficient binding, cleavage, marking and modifying
- specify temperature range for activity with modified tracrRNA
- describe sgRNA sequence with one or more stem-loop structures
- describe sgRNA sequence with two or more stem-loop structures
- describe sgRNA sequence with three or more stem-loop structures
- describe preferred sgRNA sequence
- describe importance of full-length tracrRNA for optimal ThermoCas9-based DNA cleavage
- describe removal of hairpins and its effect on cleavage efficiency
- describe stability of ThermoCas9 associated with sgRNA
- describe variation of spacer sequence length
- describe preferred spacer length

### Functional Moieties

- introduce functional moieties
- describe fusion or linking of functional moieties to Cas protein
- describe types of functional moieties
- provide example of marker protein

### Nuclease Activity

- define Cas ribonucleoprotein
- describe nuclease activity
- specify temperature range
- describe binding, cleavage, marking or modification
- specify nucleic acid types
- describe sequence-specific cleavage
- explain generation of double strand breaks
- describe endogenous cellular repair machinery
- inactivate nuclease activity
- link or fuse to functional moiety
- reduce mis-targeting events
- inactivate native Cas9 nuclease activity
- provide heterologous nuclease
- fuse to FokI nuclease domain
- provide protein complex
- target opposite strands of target genomic DNA
- attenuate nuclease activity
- utilise for diagnostic test
- inactivate and fuse to marker protein
- visualise target sequence
- describe catalytically inactive Cas protein
- repress gene expression
- create nickase
- mutate HNH or RuvC catalytic domains
- create catalytically dead Cas9 variant
- use for transcriptional silencing
- facilitate metabolic studies
- provide marker protein
- visualise target sequence
- quantify transcriptional activity
- use in homologous recombination method
- describe HR mediated genome modification
- prevent gtCas9 ribonuclease complex action
- modify or eliminate PAM sequence
- describe HR to modify microbial genome

## Expression Vectors

- introduce expression vectors
- describe expression construct
- define targeting RNA molecule
- discuss expression vector components
- list regulatory elements
- describe promoters
- discuss inducible promoters
- introduce selectable markers
- describe method of modifying target nucleic acid
- discuss transfection, transformation, or transduction
- introduce mRNA encoding Cas protein
- describe targeting RNA introduction
- discuss ribonucleoprotein complex formation
- introduce method of modifying target nucleic acid
- discuss in vitro and in vivo modification
- describe delivery systems
- introduce Adeno-associated virus (AAV) delivery
- discuss method of modifying target nucleic acid
- introduce transforming, transfecting, or transducing cells
- describe expression vector components
- discuss targeting RNA delivery
- introduce method of modifying target nucleic acid
- describe marker protein or reporter protein
- discuss fluorescent protein markers
- introduce method of visualizing target locus
- discuss nuclease or helicase-nuclease functional moiety
- introduce method of non-homologous end joining
- discuss method of homologous recombination
- introduce method of modifying gene expression
- discuss DNA modifying enzyme functional moiety
- introduce method of modifying gene expression
- discuss ribonuclease functional moiety

## Host Cells

- introduce host cells
- describe applicability of host cells
- define transformed cell
- specify Cas protein or polypeptide
- specify targeting RNA molecule
- describe expression vector
- list prokaryotic or eukaryotic cells
- specify commonly used host cells
- prefer prokaryotic cell, fungal cell, plant cell, protist cell or animal cell
- exclude human cells
- describe preferred host cells
- specify bacterial cells
- specify thermophilic bacteria
- list thermophilic bacteria species
- describe method or use for modifying genomes
- specify mesophilic bacteria
- list mesophilic bacteria species
- specify Pseudomonas putida
- describe method or use for modifying yeast or fungi
- specify mesophilic fungal species
- list Aspergillus species
- specify Candida species
- list yeast species
- specify Hansenula species
- specify Penicillium species
- specify Yarrowia species
- describe method or use for modifying thermophilic yeast or fungi
- specify thermophilic fungal species
- list thermophilic Aspergillus species
- list thermophilic Candida species
- list thermophilic yeast species
- specify thermophilic microbes
- list thermophilic bacilli
- list thermophilic clostridia
- specify preferred thermophilic microbes
- specify mesophilic bacteria
- provide polynucleotide and amino acid sequences of Cas proteins

## DETAILED DESCRIPTION

### Example 1: Isolation of Geobacillus thermodenitrificans

- isolate G. thermodenitrificans

### Example 2: Defining the Essential Consensus Sequences for Cas9 in Geobacillus thermodenitrificans

- perform database searches
- align sequences
- construct Neighbour-Joining tree
- analyze protein domain homology

### Example 3: Identifying Core Amino Acid Motifs which are Essential for the Function of CAS9 and Those which Confer Thermostability in Thermophilic Cas9 Nucleases

- align protein sequences
- identify conserved residues
- determine protein architecture

### Example 4: Determination of the PAM Sequence of G. thermodenitrificans gtCas9

- establish CRISPR system function
- describe Cas9 protein function
- explain crRNA molecule function
- predict CRISPR array
- design tracrRNA-expressing module
- design chimeric sgRNA module
- describe transcriptional terminator

### Example 5: Target Generation with Randomized PAM

- amplify spacers by PCR
- generate protospacers with randomized PAM sequences

### Example 6: In Vitro Determination of PAM Sequences for gtCas9

- construct pRham:Cas9gt vector
- transform E. cloni cells with pRham:Cas9gt vector
- isolate plasmids from E. cloni cells
- verify cas9gt gene sequence
- express gtCas9 in E. cloni cells
- prepare cell free extract (CFE) from E. cloni cells
- design sgRNA targeting plasmid library
- synthesize pT7_sgRNA DNA module
- transform DH5a E. coli cells with pUC57:pT7_sgRNA vector
- isolate plasmid from DH5a E. coli cells
- amplify pT7_sgRNA module by PCR
- perform in vitro transcription of pT7_sgRNA module
- purify sgRNA
- design and construct 7 nt long PAM library
- prepare SpPAM double stranded DNA insert
- ligate SpPAM insert with pNW33n vector
- transform DH10b cells with pNW33n:SpPAM vector
- isolate plasmid from DH10b cells
- linearize plasmid with SapI restriction enzyme
- set up cleavage reaction with gtCas9, sgRNA, and PAM library
- analyze cleavage reaction products by agarose gel electrophoresis
- tag PAM-containing DNA fragments for sequencing
- perform A-tailing with Taq polymerase
- analyze sequencing results and determine candidate PAM sequences

### Example 7: In Silico PAM Prediction for gtCas9

- identify candidate CRISPR loci in G. thermodenitrificans T12 genome
- search for matching protospacers in genome databases
- analyze flanking regions of protospacer hits for consensus PAM sequences

### Example 8: Determination of 8 Nucleotide Long PAM Sequences for gtCas9

- design specific 8 nucleotide-long PAM sequence variants
- perform in vitro cleavage assay with gtCas9 and PAM sequence variants
- analyze effect of gtCas9 concentration on cleavage activity
- analyze effect of temperature on gtCas9 activity
- determine optimal temperature range for gtCas9 activity

### Example 9: In Vivo Genome Editing of Bacillus smithii ET138 with gtCas9 and 8 Nucleotide Length PAM Sequences

- design experiment to confirm gtCas9 recognition of 8 nucleotide PAMs in vivo
- describe method of homologous recombination template construct
- introduce gtCas9 and sgRNA in homologous recombination construct
- describe pNW33n plasmid as backbone for cloning
- clone cas9_(gt) gene under glucose repressible promoter
- clone 1 kb upstream and 1 kb downstream regions of pyrF gene
- clone sgRNA expressing module under constitutive promoter
- generate three separate constructs with different spacer sequences
- describe three different targeted protospacers with PAM sequences
- transform B. smithii ET138 cells with constructs
- plate on selection plates and obtain results
- analyze results of transformation with construct number 3
- analyze results of transformation with construct number 1
- analyze results of transformation with construct number 2
- conclude that gtCas9 is active at 55Â° C. in vivo
- suggest use of gtCas9 as genome editing tool at 55Â° C.
- describe results of colony PCR to screen for pyrF gene deletion
- interpret results of transformation efficiency and cell death
- conclude that PAM sequences are recognised by gtCas9
- describe FIG. 12 and FIG. 13
- describe FIG. 14
- describe results of transformation with construct number 2
- conclude that ACGGCCAA PAM sequence is recognised by gtCas9
- introduce ThermoCas9 and its application
- describe tracrRNA structure and its effect on DNA cleavage
- evaluate effect of hairpin truncation on cleavage efficiency
- test effect of temperature on cleavage efficiency
- analyze thermostability of ThermoCas9
- compare ThermoCas9 to SpCas9
- evaluate divalent cation contribution to DNA cleavage
- test ThermoCas9 on single-stranded DNA substrates
- introduce ThermoCas9-based gene deletion in B. smithii
- describe plasmid construction for ThermoCas9-based gene deletion
- evaluate ThermoCas9 activity in B. smithii
- analyze homologous recombination efficiency in B. smithii
- introduce ThermoCas9-based gene deletion in P. putida
- describe plasmid construction for ThermoCas9-based gene deletion in P. putida
- evaluate ThermoCas9 activity in P. putida
- analyze deletion genotype in P. putida
- introduce Thermo-dCas9-based gene silencing
- describe construction of Thermo-dCas9-based CRISPRi tool
- evaluate Thermo-dCas9-based transcriptional silencing
- analyze growth of silenced cultures
- summarize CRISPR-Cas applications
- describe limitations of CRISPR-Cas technologies
- introduce ThermoCas9 as a solution to temperature limitations
- describe characterization of ThermoCas9
- analyze PAM preferences of ThermoCas9
- describe importance of sgRNA guide for ThermoCas9 activity
- summarize development of genome engineering tools
- describe application of ThermoCas9 in thermophilic and mesophilic microorganisms
- discuss value of screening natural resources for novel enzymes
- describe alternative approach to constructing thermophilic Cas9 protein
- summarize potential of ThermoCas9-based genome editing technologies
- discuss new possibilities for using Cas9 technologies
- describe significance of ThermoCas9 in genome editing
- conclude ThermoCas9 as a powerful genome engineering tool
- introduce bacterial strains and growth conditions
- describe ThermoCas9 expression and purification
- outline in vitro synthesis of sgRNA
- detail in vitro cleavage assay
- construct PAM library for in vitro PAM screen
- perform PAM screening assay
- describe editing and silencing constructs for B. smithii and P. putida
- construct pThermoCas9_ctrl, pThermoCas9_bsÎpyrF1, and pThermoCas9_bsÎpyr
- construct pThermoCas9i_ldhL vectors
- construct pThermoCas9i_ctrl vector
- construct P. putida KT2440 vector pThermoCas9_ppÎpyrF
- outline editing protocol for P. putida
- describe RNA isolation
- quantify mRNA by RT-qPCR
- perform HPLC
- introduce ThermoCas9 in Geobacillus thermoglucosidans
- describe single-plasmid approach
- detail thermoCas9 gene/sgRNA on the same plasmid
- place thermoCas9 gene under control of Î²-glucosidase promoter
- add incubation step at elevated temperature
- choose G. thermoglucosidans DSM 2542T 960 bp ldhL gene as deletion target
- generate upstream and downstream fragments of 0.9 kb by PCR
- amplify vector backbone in two parts using pThermoCas9_ctrl as template
- introduce non-targeting spacer sequence
- generate one fragment using primer combination
- generate another fragment using primer combination
- describe PCR conditions
- detail primer combinations
- outline template usage
- describe annealing temperature
- detail chromosomal DNA of G. thermoglucosidans ÎsigF as template
- describe pThermoCas9_ctrl as template
- introduce non-targeting spacer sequence
- describe primer combinations
- detail template usage
- introduce example 9
- amplify promoter
- create PCR fragments
- assemble plasmid
- transform plasmid
- extract plasmid
- confirm plasmid integrity
- transform plasmid to G. thermoglucosidans
- induce beta-glucosidase promoter
- perform colony PCR
- introduce example 19
- evaluate ThermoCas9
- amplify fragments
- assemble plasmid
- transform plasmid
- extract plasmid
- confirm plasmid integrity
- transform plasmid to B. coagulans
- induce beta-glucosidase promoter
- perform colony PCR
- introduce example 20
- evaluate ThermoCas9
- amplify fragments
- assemble plasmid
- transform plasmid
- extract plasmid
- confirm plasmid integrity
- transform plasmid to P. putida
- induce Pm promoter
- perform colony PCR
- introduce example 21
- evaluate ThermoCas9
- describe genome editing
- construct gRNA plasmid
- assemble plasmid fragments
- transform E. coli
- extract plasmid DNA
- construct repair oligo
- co-transform yeast
- analyze transformants
- demonstrate genome editing
- introduce numbered paragraphs
- describe Cas protein
- describe Cas protein fragment
- describe Cas protein temperature range
- describe DNA cleavage
- describe Cas protein source
- describe ribonucleoprotein complex
- describe targeting RNA molecule
- describe RNA molecule length
- describe target sequence length
- describe protein complex
- describe nucleic acid molecule encoding Cas protein
- define expression vector
- specify nucleotide sequence
- describe method of modifying target nucleic acid
- specify non-human cell
- describe method of modifying target nucleic acid in non-human cell
- describe method of modifying target nucleic acid in non-human cell
- describe method of modifying target nucleic acid with marker protein
- specify target nucleic acid as DNA
- specify target nucleic acid as RNA
- describe method of modifying target nucleic acid with nuclease
- describe method of silencing gene expression
- describe method of modifying or deleting and/or inserting nucleotide sequence
- describe method of modifying gene expression in non-human cell
- describe method of modifying gene expression in non-human cell
- specify temperature range for method
- specify temperature range for method
- describe method of modifying target nucleic acid in prokaryotic cell
- describe method of modifying target nucleic acid in eukaryotic cell
- describe host cell transformed by method
- use Cas protein for binding, cleaving, marking or modifying target polynucleotide
- specify temperature range for use
- specify cleavage of target polynucleotide
- specify gene silencing of target polynucleotide
- specify PAM sequence
- specify PAM sequence
- specify PAM sequence
- specify temperature range for use
- specify Cas protein obtainable from bacterium, archaeon or virus
- define genome editing method
- specify Cas9 nuclease
- describe functional moiety
- specify nuclease domain
- specify marker protein
- describe use in vivo
- specify thermophilic organism
- specify mesophilic organism
- describe gene expression modification
- describe transformed non-human cell
- specify CRISPR-associated protein
- describe targeting RNA molecule
- specify expression vector
- describe binding, cleaving, marking or modifying
- specify temperature range
- describe cleavage of target polynucleotide
- describe gene silencing
- specify PAM sequence
- describe binding, cleaving, marking or modifying at temperature
- specify Cas protein origin
- specify cell type
- describe targeting RNA molecule composition
- specify targeting RNA molecule length
- specify target nucleic acid sequence length
- describe Cas protein with functional moiety
- describe protein complex with functional moiety
- specify functional moiety fusion
- describe functional moiety options
- describe nucleoprotein complex
- describe nucleoprotein complex formation

